Search - tctmd.com

Displaying 181 - 200 of 247

Sort: Relevancy | Date

MITRA-FR in the Hot Seat as Experts Debate Impact on Guidelines and Practice

Shelley Wood

September 10, 2018

News Daily News

Valve-in-Valve TAVR Meets ‘Benchmark’ Set by Native-Valve Cases for Safety, Effectiveness

Caitlin E. Cox

July 16, 2018

Presentation The Structural Heart Disease Summit 2018

ICE Guidance of LAA Closure

Presenter: Rebecca T. Hahn, Thomas Smith, Vivek Y. Reddy

June 23, 2018

Presentation The Structural Heart Disease Summit 2018

Surgical Approaches and Emerging Data for LAA Closure: Are the Results Robust?

Presenter: Anthony N. DeMaria, Vivek Y. Reddy, Subhasis Chatterjee

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Electrical Approaches to NVAF in 2018 (Standalone or in Combination With LAA Occlusion): Evidence and Practical Recommendations

Presenter: Anthony N. DeMaria, Vivek Y. Reddy, Shephal Doshi

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

ViV in a Patient With a "Ghost" Valve and Extremely Low Left Main Trunk Takeoff

Presenter: A. Pieter Kappetein, Dee Dee Wang, Costantino Costantini, MD

June 22, 2018

Presentation The Structural Heart Disease Summit 2018

Mitral Valve-in Valve and Ring I: Insights From the VIVID Registry

Presenter: Mayra Guerrero, Lars Sondergaard, Ran Kornowski

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Pick Your Poison: Complex Aortic Valve and Mitral Valve Disease

Presenter: Patrick M. McCarthy, David Meerkin, Vivian Ng, MD

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

To Split or Not to Split: The Role of BASILICA to Reduce the Risk of Coronary Obstruction During ViV (and other TAVR) Procedures

Presenter: Vinayak Bapat, Ran Kornowski, Adam B. Greenbaum

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

To Crack or Not to Crack: The Role of Fracturing Bioprosthetic Valves During ViV Procedures

Presenter: Vinayak Bapat, Ran Kornowski, Adnan K. Chhatriwalla

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

A Tutorial on Surgical Bioprosthesis Design: Impact on ViV Therapy

Presenter: Vinayak Bapat, Ran Kornowski

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Updates from the EVOLUT R Aortic Valve-in-Valve Registry (VIVA)

Presenter: Vinayak Bapat, Ran Kornowski

June 21, 2018

Presentation The Structural Heart Disease Summit 2018

Recent Lessons from the Global Aortic VIVID Registry Optimizing Procedural Outcomes

Presenter: Vinayak Bapat, Ran Kornowski, Danny Dvir

June 21, 2018

News Conference News HRS 2018

Thrombus on the Watchman LAA Occluder Tied to Higher Stroke Risk

Todd Neale

May 14, 2018

News Daily News

Valve-in-Valve TAVR: Mortality, Adverse Events Similar to Redo Surgery at 30 Days

Yael L. Maxwell

April 25, 2018

News Conference News CRT 2018

Transcatheter Fix for Native Aortic Valve Regurgitation ‘Not Optimal’ but Getting Better

Shelley Wood

March 05, 2018

Podcast TCTMD Talking Points

PREVAIL: 5-Year Outcomes Following Left Atrial Appendage Closure in Patients With Non-Valvular Atrial Fibrillation

February 21, 2018

News Conference News ISET 2018

Next-Generation Large-Bore Closure Devices Arrive

Caitlin E. Cox

February 05, 2018

News Daily News

Structural Valve Degeneration: VIVID Group Proposes New, Graduated Definition

Michael O'Riordan

January 26, 2018

News Daily News

Preexisting Prosthesis-Patient Mismatch Signals Worse Aortic Valve-in-Valve Outcomes

Todd Neale

January 17, 2018

Advertisement

MITRA-FR in the Hot Seat as Experts Debate Impact on Guidelines and Practice

Valve-in-Valve TAVR Meets ‘Benchmark’ Set by Native-Valve Cases for Safety, Effectiveness

ICE Guidance of LAA Closure

Surgical Approaches and Emerging Data for LAA Closure: Are the Results Robust?

Electrical Approaches to NVAF in 2018 (Standalone or in Combination With LAA Occlusion): Evidence and Practical Recommendations

ViV in a Patient With a "Ghost" Valve and Extremely Low Left Main Trunk Takeoff

Mitral Valve-in Valve and Ring I: Insights From the VIVID Registry

Pick Your Poison: Complex Aortic Valve and Mitral Valve Disease

To Split or Not to Split: The Role of BASILICA to Reduce the Risk of Coronary Obstruction During ViV (and other TAVR) Procedures

To Crack or Not to Crack: The Role of Fracturing Bioprosthetic Valves During ViV Procedures

A Tutorial on Surgical Bioprosthesis Design: Impact on ViV Therapy

Updates from the EVOLUT R Aortic Valve-in-Valve Registry (VIVA)

Recent Lessons from the Global Aortic VIVID Registry Optimizing Procedural Outcomes

Thrombus on the Watchman LAA Occluder Tied to Higher Stroke Risk

Valve-in-Valve TAVR: Mortality, Adverse Events Similar to Redo Surgery at 30 Days

Transcatheter Fix for Native Aortic Valve Regurgitation ‘Not Optimal’ but Getting Better

PREVAIL: 5-Year Outcomes Following Left Atrial Appendage Closure in Patients With Non-Valvular Atrial Fibrillation

Next-Generation Large-Bore Closure Devices Arrive

Structural Valve Degeneration: VIVID Group Proposes New, Graduated Definition

Preexisting Prosthesis-Patient Mismatch Signals Worse Aortic Valve-in-Valve Outcomes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content